These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 24689548

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat.
    Pierce CL, Williams TL, Santana WI, Levine M, Chen LM, Cooper HC, Solano MI, Woolfitt AR, Marasco WA, Fang H, Donis RO, Barr JR.
    Vaccine; 2017 Sep 05; 35(37):5011-5018. PubMed ID: 28774565
    [Abstract] [Full Text] [Related]

  • 4. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry.
    Pierce CL, Williams TL, Moura H, Pirkle JL, Cox NJ, Stevens J, Donis RO, Barr JR.
    Anal Chem; 2011 Jun 15; 83(12):4729-37. PubMed ID: 21591780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
    Chen Z, Baz M, Lu J, Paskel M, Santos C, Subbarao K, Jin H, Matsuoka Y.
    J Virol; 2014 Jun 15; 88(12):7016-23. PubMed ID: 24719414
    [Abstract] [Full Text] [Related]

  • 7. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
    Gravel C, Li C, Wang J, Hashem AM, Jaentschke B, Van Domselaar G, He R, Li X.
    J Vis Exp; 2011 Apr 04; (50):. PubMed ID: 21490585
    [Abstract] [Full Text] [Related]

  • 8. Limited Tryptic Digestion-Isotope Dilution Mass Spectrometry (LTD-IDMS): A Reagent-Free Analytical Assay To Quantify Hemagglutinin of A(H5N1) Vaccine Material.
    Cooper HC, Xie Y, Palladino G, Barr JR, Settembre EC, Wen Y, Williams TL.
    Anal Chem; 2020 Sep 01; 92(17):11879-11887. PubMed ID: 32867501
    [Abstract] [Full Text] [Related]

  • 9. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
    Khurana S, Coyle EM, Verma S, King LR, Manischewitz J, Crevar CJ, Carter DM, Ross TM, Golding H.
    Vaccine; 2014 Nov 12; 32(48):6421-32. PubMed ID: 25284811
    [Abstract] [Full Text] [Related]

  • 10. Quantification of Influenza Neuraminidase Activity by Ultra-High Performance Liquid Chromatography and Isotope Dilution Mass Spectrometry.
    Solano MI, Woolfitt AR, Williams TL, Pierce CL, Gubareva LV, Mishin V, Barr JR.
    Anal Chem; 2017 Mar 07; 89(5):3130-3137. PubMed ID: 28192976
    [Abstract] [Full Text] [Related]

  • 11. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.
    De Groot AS, Ardito M, Terry F, Levitz L, Ross T, Moise L, Martin W.
    Hum Vaccin Immunother; 2013 May 07; 9(5):950-6. PubMed ID: 23807079
    [Abstract] [Full Text] [Related]

  • 12. Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness.
    Pappas C, Matsuoka Y, Swayne DE, Donis RO.
    Clin Vaccine Immunol; 2007 Nov 07; 14(11):1425-32. PubMed ID: 17913860
    [Abstract] [Full Text] [Related]

  • 13. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ, Gabbard JD, Li Z, Dlugolenski DA, Johnson SK, Tripp RA, He B, Tompkins SM.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931689
    [Abstract] [Full Text] [Related]

  • 14. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
    Zhang L, Jia N, Li J, Han Y, Cao W, Wang S, Huang Z, Lu S.
    Hum Vaccin Immunother; 2014 Dec 01; 10(7):1949-58. PubMed ID: 25424804
    [Abstract] [Full Text] [Related]

  • 15. Development of vaccine strains of H5 and H7 influenza viruses.
    Soda K, Sakoda Y, Isoda N, Kajihara M, Haraguchi Y, Shibuya H, Yoshida H, Sasaki T, Sakamoto R, Saijo K, Hagiwara J, Kida H.
    Jpn J Vet Res; 2008 Jan 01; 55(2-3):93-8. PubMed ID: 18318111
    [Abstract] [Full Text] [Related]

  • 16. Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.
    Sun Z, Wang Q, Li G, Li J, Chen S, Qin T, Ma H, Peng D, Liu X.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0068721. PubMed ID: 34585985
    [Abstract] [Full Text] [Related]

  • 17. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X, Gao Y, Ye Z.
    J Virol; 2019 Oct 01; 93(19):. PubMed ID: 31270231
    [Abstract] [Full Text] [Related]

  • 18. Development and fit-for-purpose verification of an LC-MS method for quantitation of hemagglutinin and neuraminidase proteins in influenza virus-like particle vaccine candidates.
    Guo J, Lu Y, Zhang Y, Mugabe S, Wei Z, Borisov OV.
    Anal Biochem; 2020 Mar 01; 592():113577. PubMed ID: 31926146
    [Abstract] [Full Text] [Related]

  • 19. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.
    Kodihalli S, Kobasa DL, Webster RG.
    Vaccine; 2000 May 22; 18(23):2592-9. PubMed ID: 10775793
    [Abstract] [Full Text] [Related]

  • 20. [Genetic characteristics of hemagglutinin and neuraminidase of avian influenza A (H7N9) virus in Guizhou province, 2014-2017].
    Wan YH, Zhuang L, Zheng QN, Ren LJ, Fu L, Jiang WJ, Tang GP, Zhang DZ, Li SJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov 10; 39(11):1465-1471. PubMed ID: 30462955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.